IL-32 producing CD8 memory T cells and Tregs define the IDO1 / PD-L1 niche in human cutaneous leishmaniasis skin lesions

Nidhi S. Dey,Shoumit Dey,Naj Brown,Sujai Senarathne,Luiza Campos Reis,Ritika Sengupta,Jose Angelo L. Lindoso,Sally James,Lesley Gilbert,Mitali Chatterjee,Hiro Goto,Shalindra Ranasinghe,Paul M. Kaye
DOI: https://doi.org/10.1101/2024.01.02.23300281
2024-01-03
Abstract:Human cutaneous leishmaniasis (CL) is characterised by chronic skin pathology. Experimental and clinical data suggest that immune checkpoints (ICs) play a crucial role in disease outcome but the cellular and molecular niches that facilitate IC expression during leishmaniasis are ill-defined. We previously showed that in Sri Lankan patients with CL, indoleamine 2,3-dioxygenase 1 (IDO1) and programmed death-ligand 1 (PD-L1) are enriched in lesion skin and that reduced PD-L1 expression early after treatment onset predicted cure rate following antimonial therapy. Here, we use spatial cell interaction mapping to identify IL-32-expressing CD8 memory cells and regulatory T cells as key components of the IDO1 / PD-L1 niche in Sri Lankan CL patients and in patients with distinct forms of dermal leishmaniasis in Brazil and India. Furthermore, the abundance of IL-32 cells and IL-32 CD8 T cells at treatment onset was prognostic for rate of cure in Sri Lankan patients. This study provides a unique spatial perspective on the mechanisms underpinning IC expression during CL and a novel route to identify additional biomarkers of treatment response.
Infectious Diseases (except HIV/AIDS)
What problem does this paper attempt to address?